acetylcysteine and Cortical Lewy Body Disease

acetylcysteine has been researched along with Cortical Lewy Body Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bajic, N; Ballard, CG; Francis, PT; Jenner, P1
Jenner, P; McNaught, KS; Olanow, CW; Perl, DP; Shashidharan, P1
Ballard, C; Iravani, MM; Jenner, P; MacInnes, N; Perry, E; Perry, R; Piggott, M1
Hashimoto, M; Hsu, LJ; Masliah, E; Takeda, A; Takenouchi, T1
Larsen, KE; Rideout, HJ; Stefanis, L; Sulzer, D1

Other Studies

5 other study(ies) available for acetylcysteine and Cortical Lewy Body Disease

ArticleYear
Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture.
    Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:12

    Topics: Acetylcysteine; alpha-Synuclein; Animals; Blotting, Western; Cells, Cultured; Cysteine Proteinase Inhibitors; Immunohistochemistry; Lewy Body Disease; Neurons; Neuropeptides; Oligopeptides; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Synapses; Synaptophysin; Tubulin; Ubiquitination

2012
Aggresome-related biogenesis of Lewy bodies.
    The European journal of neuroscience, 2002, Volume: 16, Issue:11

    Topics: Acetylcysteine; Antigens; Brain; Canavanine; Centrosome; Dose-Response Relationship, Drug; Golgi Apparatus; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Nerve Tissue Proteins; Neurons; Parkinson Disease; Peptide Hydrolases; Protein Folding; Synucleins; Tubulin; Ubiquitins

2002
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:6

    Topics: Acetylcholine; Acetylcysteine; Aged; Aged, 80 and over; alpha-Synuclein; Animals; Basal Nucleus of Meynert; Cell Death; Cells, Cultured; Cerebral Cortex; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Lewy Bodies; Lewy Body Disease; Male; Nerve Degeneration; Nerve Tissue Proteins; Neural Pathways; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Rats, Sprague-Dawley; Ubiquitin

2008
Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
    The Journal of biological chemistry, 1999, Oct-08, Volume: 274, Issue:41

    Topics: Acetylcysteine; alpha-Synuclein; Antioxidants; Brain; Cytochrome c Group; Deferoxamine; Humans; Hydrogen Peroxide; Immunohistochemistry; Lewy Body Disease; Nerve Tissue Proteins; Oxidative Stress; Recombinant Proteins; Synucleins

1999
Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
    Journal of neurochemistry, 2001, Volume: 78, Issue:4

    Topics: Acetylcysteine; alpha-Synuclein; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Cell Differentiation; Cyclic AMP; Cysteine Endopeptidases; Immunoblotting; Immunohistochemistry; Inclusion Bodies; Lewy Body Disease; Multienzyme Complexes; Nerve Tissue Proteins; Neuroprotective Agents; Oligopeptides; Parkinson Disease; PC12 Cells; Protease Inhibitors; Proteasome Endopeptidase Complex; Rats; Synucleins; Ubiquitins

2001